01134nam 2200325 n 450 99639100860331620221108072129.0(CKB)1000000000665392(EEBO)2240866007(UnM)99851348(EXLCZ)99100000000066539219920331d1585 uy |laturbn||||a|bb|In illustrissimi comitis Leicestrensis Oxoniensis Academiæ cancellarij, reliquoruinq[ue][electronic resource] nobilium exoptatissimum aduentum, Carmen GratulatoriumOxoniæ Ex ædibus Iosephi Barnesquinto Idus Ianuarij. 15851 sheet ([1] p.)In verse.Caption title.Reproduction of the original in the British Library.eebo-0018Leicester Robert DudleyEarl of,1532?-1588.935413Cu-RivESCu-RivESCStRLINWaOLNBOOK996391008603316In illustrissimi comitis Leicestrensis Oxoniensis Academiæ cancellarij, reliquoruinq2374072UNISA01304nam2 22003011i 450 UON0022829120231205103448.58588-16-30035-320030730d1991 |0itac50 baitaIT|||| ||||| Nello spazio della metafisical'epoca modernaHans Urs von Balthasartrad. di Guido SommavillaMilano : Jaca Book1991599 p.24 cmTit. orig.: Im Raum der Metaphysik.001UON000666062001 Già e non ancora35001UON001776092001 Gloriauna estetica teologicaHans Urs von Balthasar205 Milano : Jaca Book1978 (1a rist. 1985)210 7 v.24 cm215 Tit. orig.Herrlichkeit.Vol. 5ITMilanoUONL000005BALTHASARHans Urs vonUONV118888452111SOMMAVILLAGuidoUONV138355Jaca BookUONV245945650ITSOL20240220RICASIBA - SISTEMA BIBLIOTECARIO DI ATENEOUONSIUON00228291SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI CONS. FP III 0160 5 SI FP 6532 7 5 Nello spazio della metafisica297079UNIOR05319nam 2200673Ia 450 991102024210332120200520144314.09786612683091978128268309912826830989783527622733352762273X97835276227403527622748(CKB)1000000000707663(EBL)482031(SSID)ssj0000112451(PQKBManifestationID)11830358(PQKBTitleCode)TC0000112451(PQKBWorkID)10097324(PQKB)10896151(MiAaPQ)EBC482031(OCoLC)352869288(Perlego)2752840(EXLCZ)99100000000070766320081201d2009 uy 0engur|n|---|||||txtccrBiotech funding trends insights from entrepreneurs and investors /Alexandra Carina GruberWeinheim Wiley-Blackwellc20091 online resource (212 p.)Description based upon print version of record.9783527324354 3527324356 Includes bibliographical references (p. 137-139) and index.Biotech Funding Trends: Insights from Entrepreneurs and Investors; Contents; Preface; Acknowledgments; Limit of Liability/Disclaimer of Warranty; Executive Summary; 1 Introduction; 1.1 Development of the Private Equity and Venture Capital Market; 1.1.1 Denition; 1.1.2 Historical Background; 1.1.3 The Challenges to Private Equity in Europe; 1.1.4 Private Equity and Venture Capital Performance in Europe by Country; 1.1.5 The Future of Private Equity and Venture Capital in Europe; 1.2 Development of the Biotech Industry; 1.2.1 Definition; 1.2.2 Historical Background1.2.3 Financing Biotech Start-ups1.2.4 Exit Routes in the Biotech Industry; 1.2.5 The Challenges to European Biotech; 1.2.6 The Future of the European Biotech Industry; 2 Methodology; 2.1 Formulating the Research Goal; 2.1.1 The Entrepreneur's Dilemma; 2.1.2 The Investor's Dilemma; 2.1.3 Financing Models; 2.1.4 Interpersonal Relationships and Cooperations; 2.1.5 Practical Guidelines for Entrepreneurs and Venture Capitalists; 2.2 Conducting the Study; 2.2.1 Qualitative Interviews; 2.2.2 Selection of Interview Partners; 2.3 Evaluating the Results; 3 Data Analysis and Interpretation of Results3.1 Description of Interview Partners3.1.1 Entrepreneurs; 3.1.2 Venture Capitalists; 3.1.3 Other Investors; 3.2 Major Characteristics of an Entrepreneur; 3.2.1 The Dual Role of the Entrepreneur; 3.3 Major Characteristics of a Venture Capitalist; 3.3.1 Global Reach of the Fund; 3.4 The Most Important Partnering Criteria; 3.4.1 The Entrepreneur's Perspective; 3.4.2 The Venture Capitalist's Perspective; 3.4.3 The Perspective of Other Investors; 3.5 Financing Models; 3.5.1 Most Important Financing Models; 3.5.2 New and Creative Financing Approaches3.5.3 Differences Between Early- and Late-stage Financing3.5.4 Differences Between Early- and Late-stage Valuation Techniques; 3.6 Biotech Research Areas; 3.6.1 Vaccines; 3.6.2 Biotech Drug Development or Medical Technology and Devices?; 3.7 Alliances and Funding in the Early Stage; 3.7.1 Networking Between Venture Capitalists and Universities and Their Scientists; 3.7.2 The Role of Government Grants; 3.7.3 The Role of Business Angels; 3.7.4 Preferred Deal Structure; 3.7.5 Structuring the Board of Directors; 3.8 Alliances and Funding in the Late Stage3.8.1 Networking with Corporate Venture Capitalists3.8.2 The Role of Banks as Capital Investors; 3.8.3 The Importance of Milestone Payments; 3.9 Exit Routes; 3.9.1 Exit Preferences; 3.9.2 The Role of New Markets; 3.9.3 Prominent European IPO Success Stories; 3.10 Primary Causes of Failure; 3.10.1 The Entrepreneur's Perspective; 3.10.2 The Venture Capitalist's Perspective; 3.10.3 The Perspective of Other Investors; 3.11 Best-practice Countries for Funding Biotech Start-ups; 3.11.1 The Entrepreneur's Perspective; 3.11.2 The Venture Capitalist's Perspective3.11.3 The Perspective of Other InvestorsBased on interviews with successful biotech entrepreneurs and high-level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment.A must-have for biotech entrepreneurs and investors, as well as invaluable suBiotechnology industriesEuropeFinanceBiotechnologyEuropeBiotechnology industriesFinance.Biotechnology228.4/36606094338.476606Gruber Alexandra Carina1971-1842390MiAaPQMiAaPQMiAaPQBOOK9911020242103321Biotech funding trends4422465UNINA